US Patent

US10729653 — Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives

Formulation · Assigned to UCB Biopharma SRL · Expires 2030-04-09 · 4y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects an immediate release formulation of pharmaceutical compounds.

USPTO Abstract

The present invention relates to an immediate release formulation of pharmaceutical compounds.

Drugs covered by this patent

Patent Metadata

Patent number
US10729653
Jurisdiction
US
Classification
Formulation
Expires
2030-04-09
Drug substance claim
No
Drug product claim
Yes
Assignee
UCB Biopharma SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.